Sorrento Therapeutics (SRNE) Insider Trading & Ownership → Now Open: Crypto emergency update (From InvestorPlace) (Ad) Free SRNE Stock Alerts $0.03 0.00 (0.00%) (As of 04/18/2024 ET) Add Compare Share Share Insider TradesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainSEC FilingsSocial MediaSustainabilityStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainSEC FilingsSocial MediaSustainability Sorrento Therapeutics (NASDAQ:SRNE) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage2.60%Number OfInsiders Buying(Last 3 Years)1Amount OfInsider Buying(Last 3 Years)$59,777.32Number OfInsiders Selling(Last 3 Years)1Amount OfInsider Selling(Last 3 Years)$421,663.14 Get SRNE Insider Trade Alerts Want to know when executives and insiders are buying or selling Sorrento Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address SRNE Insider Buying and Selling by Quarter Ad DTIBiden’s $374B Giveaway Into This SectorBiden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right hereClick here for the full story Sorrento Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/25/2022Henry JiInsiderBuy22,222$2.06$45,777.32 6/14/2022Henry JiInsiderBuy10,000$1.40$14,000.00 12/27/2021Kim JandaDirectorSell3,000$5.88$17,640.00 9/27/2021Kim JandaDirectorSell42,357$8.02$339,703.14 9/13/2021Kim JandaDirectorSell8,000$8.04$64,320.00 (Data available from 1/1/2013 forward) SRNE Insider Trading Activity - Frequently Asked Questions Who is on Sorrento Therapeutics's Insider Roster? The list of insiders at Sorrento Therapeutics includes Henry Ji, and Kim Janda. Learn more on insiders at SRNE. What percentage of Sorrento Therapeutics stock is owned by insiders? 2.60% of Sorrento Therapeutics stock is owned by insiders. Learn more on SRNE's insider holdings. Which Sorrento Therapeutics insiders have been buying company stock? The following insider purchased SRNE shares in the last 24 months: Henry Ji ($59,777.32). How much insider buying is happening at Sorrento Therapeutics? Insiders have purchased a total of 32,222 SRNE shares in the last 24 months for a total of $59,777.32 bought. More Insider Trading Tools from MarketBeat Related Companies: Coeptis Therapeutics Insider Trading Inhibikase Therapeutics Insider Trading Organovo Insider Trading BioCardia Insider Trading Creative Medical Technology Insider Trading Surrozen Insider Trading Titan Pharmaceuticals Insider Trading Aptose Biosciences Insider Trading Fresh Tracks Therapeutics Insider Trading Palisade Bio Insider Trading Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: The 5 Stocks Most Sold By Insiders This Year3 Cheap Stocks Insiders are Buying: Investors Should Avoid 1The 5 Hottest CEO Stock Purchases So Far This Year3 Cheap Stocks that Insiders Bought in Q1Michael Burry Picked a Winner With GEN Restaurant Group This page (NASDAQ:SRNE) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThe “Perfect Storm” for GoldGold Safe ExchangeBiden’s $374B Giveaway Into This SectorDTIForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressThe #1 Crypto for 2024InvestorPlaceHe Is Giving Away BitcoinCrypto Swap ProfitsYour Money is Not SafeAmerican AlternativeThe "Smart Money" Is Ready for May 1st Are You?Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sorrento Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.